Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
Titel:
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
Auteur:
Pollard, Andrew J Launay, Odile Lelievre, Jean-Daniel Lacabaratz, Christine Grande, Sophie Goldstein, Neil Robinson, Cynthia Gaddah, Auguste Bockstal, Viki Wiedemann, Aurelie Leyssen, Maarten Luhn, Kerstin Richert, Laura Bétard, Christine Gibani, Malick M Clutterbuck, Elizabeth A Snape, Matthew D Levy, Yves Douoguih, Macaya Thiebaut, Rodolphe